(Q48629778)

13 February 2018

title

Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease. (English)

1 reference

13 February 2018

1 reference

6

1 reference

13 February 2018

author name string

Jörg Spiegel

1

1 reference

13 February 2018

Dirk Hellwig

2

1 reference

13 February 2018

Marc-Oliver Möllers

3

1 reference

13 February 2018

Stefanie Behnke

4

1 reference

13 February 2018

Wolfgang Jost

5

1 reference

13 February 2018

Samuel Samnick

7

1 reference

13 February 2018

Ulrich Dillmann

8

1 reference

13 February 2018

Georg Becker

9

1 reference

13 February 2018

Carl-Martin Kirsch

10

1 reference

13 February 2018

language of work or name

English

0 references

publication date

2 March 2006

1 reference

13 February 2018

published in

Brain

1 reference

13 February 2018

volume

129

1 reference

13 February 2018

issue

Pt 5

1 reference

13 February 2018

page(s)

1188-1193

1 reference

13 February 2018

Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound

cites work

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Perspectives of B-mode transcranial ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Iron accumulation in the substantia nigra in rats visualized by ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Echogenicity of substantia nigra determined by transcranial ultrasound correlates with severity of parkinsonian symptoms induced by neuroleptic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Five-year follow-up study of hyperechogenicity of the substantia nigra in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Screening for mutations of the IRP2 gene in Parkinson's disease patients with hyperechogenicity of the substantia nigra.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [123I]beta-CIT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Magnetic resonance relaxometry in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Possible environmental, occupational, and other etiologic factors for Parkinson's disease: a case-control study in Germany.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWL042

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWL042

1 reference

13 February 2018

1 reference

13 February 2018